The Merck Digital Sciences Studio (MDSS) empowers early-stage startups specializing in digitally enabled technologies for drug discovery, pre-clinical, and clinical development through funding, mentoring, and access to Merck’s global network.
Applications are now open for the 2026 North America cohorts (United States & Canada).
The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development.
Selected startups gain direct access to Merck experts, personalized mentoring from Centech advisors, and a SAFE investment from the Merck Global Health Innovation Fund (GHI), in collaboration with regional partners The Venture Collective (United States) and CQDM (Canada). Through this collaborative approach, MDSS connects innovators, researchers, and industry leaders to accelerate breakthroughs in health technology.

.png)

MDSS values diversity across all its programs and investments. We believe founder diversity is more than just an asset, but an investor advantage for building outperforming startups. MDSS is committed to cultivating diversity in our portfolio and the broader ecosystem. We encourage founders from all walks of life, backgrounds, and experiences to apply to our studio programs.
Oops! Something went wrong while submitting the form